Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry.
about
Causes of Death Following Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-AnalysisEuropean real world trans-catheter aortic valve implantation: systematic review and meta-analysis of European national registriesSimple, effective and safe vascular access site closure with the double-ProGlide preclose technique in 162 patients receiving transfemoral transcatheter aortic valve implantation.Emergency cardiac surgery during transfemoral and transapical transcatheter aortic valve implantation: incidence, reasons, management, and outcome of 411 patients from a single center.Management of the patient for transcatheter aortic valve implantation in the perioperative period.Sudden Death After Transcatheter Aortic Valve Implantation. Are Bradyarrhythmias Always The Cause?Transcatheter aortic valve replacement-state of the art and a glimpse to the future: 'the Tailored Approach'The Edwards SAPIEN Transcatheter Heart Valve for Calcific Aortic Stenosis: A Review of the Valve, Procedure, and Current Literature.Transcatheter aortic valve implantation and cerebrovascular events: the current state of the art.Initial experiences of young cardiologists with balloon-expandable transcatheter aortic valve implantation in Turkey: a case series of eleven patients.Change in quality of life after transcatheter aortic valve implantation and aortic valve replacement surgery in Australian patients aged ≥ 75 years: the effects of EuroSCORE and patient operability.Transcatheter aortic valve implantation in end-stage renal diseaseEarly- and mid-term outcomes after transcatheter aortic valve implantation. Data from a single-center registry.Clinical studies assessing transcatheter aortic valve replacement.The first korean patient with severe aortic stenosis and bilateral iliofemoral artery disease treated with transcatheter aortic valve implantation by transsubclavian approachComparison 30-day clinical complications between transfemoral versus transapical aortic valve replacement for aortic stenosis: a meta-analysis reviewUpdate of transcatheter valve treatment.Patient selection for transcatheter aortic valve implantation: An interventional cardiology perspectivePerspective on the cost-effectiveness of transapical aortic valve implantation in high-risk patients: Outcomes of a decision-analytic model.Comparison of multicenter registries and randomized control trials for transcatheter aortic valve replacement (TAVR).Impact of mean platelet volume on combined safety endpoint and vascular and bleeding complications following percutaneous transfemoral transcatheter aortic valve implantation.Recent advances in transcatheter aortic valve implantation: novel devices and potential shortcomings.Recognition and management of complications during transcatheter aortic valve implantation.Vascular closure after transcatheter aortic valve interventions--the current state of play.Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications.TAVI 2012: state of the art.Maintaining a minimally invasive approach-vascular closure after trans-catheter aortic valve intervention.Clinical and prognostic implications of existing and new-onset atrial fibrillation in patients undergoing transcatheter aortic valve implantation.Percutaneous transcatheter aortic valve implantation: present and future perspective.Access site bleeding after transcatheter aortic valve implantation.Transcatheter aortic valve replacement: techniques, complications, and bailout strategies.Worldwide TAVI registries: what have we learned?Transcatheter aortic valve implantation: technique, complications and perspectives.Antithrombotic therapy before, during and after transcatheter aortic valve replacement (TAVR).Stroke after transcatheter aortic valve replacement: incidence, risk factors, prognosis, and preventive strategies.A balloon-expandable sheath facilitates transfemoral TAVR in patients with peripheral vascular disease and tortuosity.Complications and Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement With Edwards SAPIEN & SAPIEN XT Valves: A Meta-Analysis of World-Wide Studies and Registries Comparing the Transapical and Transfemoral Accesses.Clinical impact and evolution of mitral regurgitation following transcatheter aortic valve replacement: a meta-analysis.Two-year post-discharge costs of care among patients treated with transcatheter or surgical aortic valve replacement in Germany.Midterm clinical outcome following Edwards SAPIEN or Medtronic Corevalve transcatheter aortic valve implantation (TAVI): Results of the Belgian TAVI registry.
P2860
Q26782652-190A0D3D-1194-4CE6-867D-9442002365D3Q28078840-F8A11AF4-57D4-4E9F-8393-C85DD0FFF2B8Q30317794-44360FB8-65E3-45BE-8F79-6ECFA7557889Q30317795-E48178FA-BE18-4E08-AD17-8CE9BC9D072EQ30454993-E7AEF300-A553-43BD-8F68-02D2EF9742C6Q33168005-AA1D225E-F38D-44D5-BD0D-8FFCFDD1BD7CQ33646856-CFBF6335-436E-4200-B272-9F44DBAC67BAQ33936143-254B84F4-B257-4C8E-AFF1-9FFBB9A14EF6Q34252757-5052D741-616D-4D91-8012-33A881D3BC26Q34667097-25B09E8F-80C5-4294-9072-CD8FCB9F7357Q35019671-FBF23E0A-D961-4919-B17F-9800AC6B097EQ35452614-C28A61F9-4DFE-4469-8855-63237BE18C17Q36046152-A69A0E11-653E-4341-ACA3-4D8B7D23F964Q36119341-2122A3EC-B287-43A8-9A6A-B7EB00310B95Q36457145-090E39BA-B53A-44B8-9EC1-C0F1A6B93771Q37042558-A05174A0-6FC0-4469-AC4A-CA48A3C234BAQ37076586-609CE264-AB30-418D-8FA8-493256C45E45Q37090699-47199323-E88E-4960-B32F-7222C0ADC67BQ37090742-76671A51-1656-47FA-AD6B-355DA8A42D8CQ37387631-92D7C4C7-9588-4386-BB3B-D6341FB66891Q37451038-F469C6DB-1635-4834-8B79-EB2209F783E0Q37614906-90B6B426-C504-4045-BE5F-B263680A7ED1Q37910214-2550097C-3704-4FDE-AA21-FD5D7019D1B9Q38020877-53155BC6-96CB-4E3B-88BD-30C09F116988Q38031218-6DECB436-9458-4B0D-A147-FBA7448854D5Q38056817-0862D44C-1659-47A3-A31C-6FDE38C2A8B2Q38067676-97D2DBB9-F552-416E-82E8-A958427E64D8Q38069956-59631869-AEFD-4B6B-A1FF-18467972B104Q38088269-5486B24B-18A0-48D5-9F19-4559C5E607C5Q38103787-74444445-C5FE-46B5-B36A-6701BB1F54ECQ38151447-5D3352FE-867A-4DD8-8FFF-14E6EBD16FB1Q38197558-54EBE0AA-9FDB-4B3A-AAA4-07C3C8AD4A69Q38228842-F9457AA1-AFEF-4C60-BF10-68D6364A5B24Q38237936-93A3AB35-CF6B-4CD1-A88A-952AFE11FD51Q38268827-AE933B46-62A9-4A41-B559-6DDD6D9CB0CFQ38382390-32AB1795-7C36-40FD-A435-6DDB48DD53C9Q38492573-9686AD25-4659-47A2-BEB1-94BDA5F7235AQ38523149-BDD28D43-D016-404D-8FE9-F802A2175DA6Q38659988-28A37499-5C62-4B63-9DAB-37B8EEBD79F7Q40950302-B25161DA-7E62-46B2-AD6A-52D35540A95F
P2860
Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Procedural, 30-day and one yea ...... the Belgian national registry.
@ast
Procedural, 30-day and one yea ...... the Belgian national registry.
@en
Procedural, 30-day and one yea ...... the Belgian national registry.
@nl
type
label
Procedural, 30-day and one yea ...... the Belgian national registry.
@ast
Procedural, 30-day and one yea ...... the Belgian national registry.
@en
Procedural, 30-day and one yea ...... the Belgian national registry.
@nl
prefLabel
Procedural, 30-day and one yea ...... the Belgian national registry.
@ast
Procedural, 30-day and one yea ...... the Belgian national registry.
@en
Procedural, 30-day and one yea ...... the Belgian national registry.
@nl
P2093
P1476
Procedural, 30-day and one yea ...... the Belgian national registry.
@en
P2093
Belgian TAVI Registry Participants
Bernard De Bruyne
Christophe Dubois
Inez Rodrigus
Johan M Bosmans
Joëlle Kefer
Paul Herijgers
Stephan Verheye
Victor Legrand
P304
P356
10.1510/ICVTS.2010.253773
P577
2011-02-24T00:00:00Z